This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vascular Access Systems Market

Market Insights on Vascular Access Systems covering sales outlook, demand forecast & up-to-date key trends

Vascular Access Systems Market: Global Industry Analysis and Opportunity Assessment 2022-2032

Vascular Access Systems Market Outlook 2022-2032

In 2022, the vascular access systems market is anticipated to be worth US$ 4.74 billion. Vascular access devices market is projected to expand at a significant CAGR of 6.64% and is projected to reach up to US$ 9.02 billion by 2032.

Attributes

Details

Vascular Access Systems Market CAGR

6.64%

Vascular Access Systems Market Size 2022

US$ 4.74 billion

Vascular Access Systems Market Size 2032

US$ 9.02 billion

Vascular access systems are intended for a series of diagnostic tests and treatments such as central venous pressure readings, blood sampling, fluid infusion, blood transfusion, parenteral and drugs administration such as chemotherapeutic agents, analgesics, antibiotics.

Vascular access systems can be defined as the material which is implanted subcutaneously in a region over the upper chest wall, having a dwell time of nearly 14 days, with the catheters inserted in the sub clavian vein, jugular vein, or basilic vein.

Customize this Report

Let us know your requirement to get
100% FREE customization

Market Determinants

In the upcoming years, the demand for vascular access systems is expected to increase significantly due to a number of factors, including the rising prevalence of end-stage renal diseases and the rising number of vascular access surgeries.

While some central venous catheters can remain in place for extended periods of time, some catheters need to be replaced because of poor performance.

Few people have poor vein health, which is completely unsuitable for catheter implantation. Venous injury develops over time as a result of persistent vein access. These all contribute to the vascular access systems market restraints.

The demand for vascular access systems by medical professionals in hospitals, emergency departments, and operating rooms has greatly increased in recent years because to the steady growth in diseases including cancer, trauma, and acute illness around the world. Adding to the vascular access systems market growth catalyst.

Regional Insights

North America now tends to dominate the vascular access systems market in terms of revenue share, and it is anticipated that this trend will continue during the projection period.

The European vascular access systems market will, however, be visibly threatened by North America's dominance. This dominance is ascribed to three factors: the rising incidence of cardiovascular diseases, the rising incidence of end-stage renal diseases, and the rising incidence of cancer.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Competitive Landscape

In order to gain market share, a number of small to mid-sized businesses are fiercely competing in the vascular access devices market. However, a select few businesses, such as B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, NIPRO Medical Corporation, and Fresenius Medical Care, are doing well on the vascular access systems market.

Recent Development

The new Introcan Safety 2 IV Catheter with one-time blood control was introduced by B. Braun Medical Inc. (B. Braun) in July 2022. The most recent invention from B. Braun makes IV access safer for the clinician by lowering the possibility of needlestick injuries and their exposure to blood.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Utilisation of Vascular Access Systems Depends Upon Medical Conditions and Requirements

Central Venous Access systems are essential for the care of many sick children. In order to reduce the risk of infection and thrombosis and also to increase the line longevity, appropriate type of catheter must be selected and inserted in a standardized procedure.

Vascular access systems market covers implantable-ports, Huber needles, (PICCs) peripherally inserted central catheters, (CVCs) central venous catheters, dialysis catheters, needleless connectors, needles and syringes.

The usage of these medical systems depends on various medical conditions and its requirements that may include the purpose for its requirements, size of the device, the duration of time it needs to be in-situ.

Peripheral Vascular Access Systems- Appropriate for Short-Term Therapies

Peripheral vascular access systems are the most appropriate for short term therapies as they cause less irritation. A peripherally inserted central catheter is inserted through antecubital fossa vein, which may be basilic or cephalic, further progresses through the superior vena cava. The position of the catheter’s tip is radiologically confirmed.

The procedure are relatively easy to insert. This makes them a potentially more economically option. The risk involved for the rate of thrombosis and sepsis is lowered. The risk of large vein perforation and pneumothorax is also reduced, which is linked to centrally inserted catheters.

Whereas central vascular access systems are used in cases like medicines having greater pH than 9.0 or less than 5.0, parentral nutrition with glucose concentration greater than 10%, infusion fluids which are known irritants, intra venous inotropes and vesicants.

Tunneled Central Venous Catheters Restrict Infection from Reaching the Bloodstream

Tunneled central venous catheter are known as Hickmann lines. These are more often required when the patient is on long-term infusion therapy, example chemotherapy, and total parentral nutrition and also provide access for taking blood samples.

This type of line is manufactured in the form of large-bore silicone line having single or double lumen. Tunneled lines can be used for long-term infusion therapy with the time duration ranging from months to years.

The tip of the catheter is directly inserted into the subclavian vein or jugular and then it is threaded through to end up in the superior vena cava. Various tunneled central venous catheters are equipped with a fibrous cuff.

These are assembled in the skin tunnel. This enables the tissue of the patient to bond with the line so as to create a secure fix. This mechanical barrier stops infection from reaching the bloodstream to cause sepsis.

These central venous catheters can be of two types, namely open-ended or valved. This type of line insertion is done usually in theatre or radiology with the help of an image intensifier for the correct positioning of the catheter.

Insertion of Non-Tunneled Catheter Requires Strict Sterile Conditions

The non-tunneled type is often known as a short-term percutaneous central venous catheter and is most commonly used central venous catheter in secondary care. It is directly inserted into a central vein. Strict sterile conditions are required for the insertion of this type of catheter.

The positioning of non-tunneled catheter is to be confirmed using radiological devices. The Jugular region (area near to the neck) is more susceptible to infection because of the difficulty of placing the catheter to the neck of the patient securely.

Implantable ports are vascular access systems inserted into the chest, antecubital area or abdomen. They are useful in long-term intravenous therapy, blood sampling, bolus injections and total parentral nutrition.

Adoption of Implantable Ports Lowered Post-Recent Advancements in Vascular Access Devices

The recent advancement in the vascular access devices such as central venous catheter and peripheral inserted central catheters have lowered the use of implantable ports.

Ports are inserted subcutaneously. Implantable ports are often preferred by the patient because they are less visible. Medical staff prefer them as they are linked with less risk and are easily accessed. These ports can remain in situ for up to seven days.

Ports have been used for epidural pain relief and can be used alternatively for subcutaneous infusions. The condition of being unobstructed is maintained by rinsing heparin solution after definite intervals. It involves minimal manipulation and care.

Vascular Access Systems Market: Drivers and Restraints

As some of the central venous catheter can be in place for months together but replacement is required for few catheters due to the poor functioning. Certain types of ports have a life of reservoir septum of about 1000 puncture that is not at all suitable for patients who require daily IV access.

Few patients have poor vein condition which is not at all suitable for placement of catheter. Long term access of the veins eventually lead to the vein damage (example: long term IV feeding). These all factors contributes to the restraints of the vascular access market.

Globally, there is a constant rise in number of diseases like as cancer, trauma, and acute illness which has significantly raised the demand of proficient vascular access systems in recent years by healthcare professionals in hospitals, emergency rooms, and operation theaters. Further contributing to the driver for the vascular access system market.

Vascular Access Systems Market: Overview

Depending on geographic region, global vascular access system market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America holds the largest share of the global vascular access systems due to the cumulative aging population and extensive technological advancement.

Vascular Access Systems Market: Region-wise Outlook

Based on geographic region, global vascular access system market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.

North America holds the largest share of the global vascular access systems owing to the cumulative aging population and extensive technological advancement.

Cluster Headache Syndrome Market: Key Players

Nipro Medical Corporation, B. Braun Medical Inc., Edwards Life sciences Corporation, Medtronic, Siemens Medical Solutions Inc., Baxter, , GE Healthcare Inc., Teleflex Medical and. Becton, Dickinson and Company.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Western Europe (Germany, Italy, Spain, France, U.K, Rest Of Western Europe)
  • Eastern Europe (Poland, Russia, Rest of Eastern Europe)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC countries, S. Africa, Rest of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Vascular Access Systems Market: Segmentation

By Product:

  • Central Vascular Access System
  • Central Vascular Catheter
  • Non tunneled
  • Tunneled
  • Implanted Ports
  • Peripheral Vascular Access System
  • Peripheral Catheter
  • Midline Catheter

By End User:

  • Hospital Pharmacy
  • Ambulatory Surgical Centre
  • Hospital Pharmacy
  • Catheterization Lab

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excl. Japan
  • Japan
  • MEA

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Vascular Access Systems Market